Brief: Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1
28/01/2025 12:39
Jan 28 (Reuters) - Telomir Pharmaceuticals Inc TELO.O :
* TELOMIR PHARMACEUTICALS INC - ANNOUNCES BREAKTHROUGH
RESULTS
WITH TELOMIR-1
* TELOMIR PHARMACEUTICALS INC - TELOMIR-1 REVERSES
COPPER-INDUCED
ROS ELEVATION IN HUMAN CELL LINES
Source text: ID:n0001493152-25-003909
Further company coverage: TELO.O
(Reporting by Siddhi Mahatole)
((SiddhiPrabhanjan.Mahatole@thomsonreuters.com;))
Recent news on Telomir Pharmaceuticals
See all newsBrief: Telomir Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality In Human Triple-Negative Breast Cancer Models
Brief: Telomir Pharmaceuticals Telomir-1 Significantly Reduced Tumor Growth And Metastases
Brief: Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’S “Kill-And-Clean” Defense Systems In An Aggressive Prostate Cancer Model
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation